| Boehringer Ingelheim Presents New Phase III Data Evaluating Linagliptin in ... - PR Newswire (press release) |
|
|
PR Newswire (press release)(2) In addition, new pharmacokinetic (PK) data demonstrate that decreases in renal function had minor effect on the elimination of linagliptin. ...New phase III data further support the safety and efficacy profile of ... read more |